A 21-year-old man presented persistent dry cough, general malaise, loss of appetite, decreased sexual desire and double vision. Chest radiograph revealed a mass shadow in the left upper lobe. Histopathological diagnosis of the tumor was squamouscell carcinoma. Brain computedtomographyand magnetic resonance imaging revealed a metastasis to the pituitary gland. Hypopituitarism was diagnosed by pituitary function tests. Diabetes insipidus was absent and the function of the posterior lobe of the pituitary gland was preserved. Hypopituitarism due to pituitary metastasis is a rare complication of lung cancer, and has never been reported in a patient as young as 21 years old. (Internal Medicine 40: 414-417, 2001) 
Introduction
Lungcancer is a commondisease mainly amongolder patients. Lung cancer in patients younger than 40 years of age is generally defined as lung cancer of the young. Lung cancer in this group often presents in an advanced stage (1, 2) . As the disease advances, metastases to various organs cause a variety of clinical manifestations. The reported incidence of pituitary metastasis is 1%to 6% (3) (4) (5) . Breast cancer is the disease most frequently associated with pituitary metastases followed by lung cancer (6) (7) (8) . Although diabetes insipidus secondary to cancer metastasis to the pituitary gland is a common manifestation, anterior pituitary failure is rare. Wepresent a 21-year-old man with hypopituitarism secondary to pituitary metastasis from lung cancer.
Case Report
A 21-year-old man who had been in good health and had never smoked, was admitted to Kurashiki Central Hospital on December 18, 1997 with a dry cough that had persisted for one month. Chest radiograph revealed a mass shadow in the left upper lobe (Fig. 1 ). For one month before admission, he had felt general malaise, loss of appetite, and decreased sexual desire. Sometimes he noted diplopia. Polydipsia and polyuria were absent and hi^body hair had not changed. He was 170 cm in height and 55.4 kg in weight. Body temperature was 36.7°C, blood pressure 140/78 mmHg,pulse rate 74/min with an irregular rhythm. There was no evidence of lymphadenopathy or goiter. Though he experienced occasional diplopia, ocular movement was normal in all directions and disturbance of convergence was not seen. The visual fields were intact in the perimetry. The pupils were equal, round and reactive to light. On chest examination,there wereno crackles or wheezesand heart sounds were normal. Neither gynecomastia nor galactorrhea was present. Onabdominal examination, there was no hepatosplenomegaly and no palpable mass. There was no peripheral edema in the extremities. Complete blood count showed the following: hemoglobin 15.8 g/dl, white cell count 9,200/ul, and platelet count 26.3x 107 |xl. Evaluation of serum chemistry revealed lactate dehydrogenase 944 IU//, sodium 138 mEq//, potassium 3.6 mEq//, fasting blood glucose 4.6 mM(83 mg/dl). Evaluation of tumor markers showedsquamouscell carcinoma associated antigen 0.9 ng/ml (normal 0-1.5), carcinoembryonic antigen 1.0 ng/ ml (0-2.5), neuron-specific enolase 6.5 ng/ml (0-10), and cytokeratin 19 fragment 3.9 ng/ml (0-3.5). Urine amount was 1,700 ml daily. The spun urinary sediments contained 10 to 20 erythrocytes per high-power field. Initial evaluation with computed tomography (CT) of the chest revealed an irregularly margined mass in the left S3 extending from the left hilar and swelling of mediastinal lymph nodes. Fiberoptic bronchoscopy showed obstruction of the left B3 bronchus and the lingula bronchus by a tumor. Histopathologic examination of a biopsy specimen of the tumor revealed squamous cell carcinoma. A contrast-enhanced CTscan of the whole body on January 5, 1998, showed hypovascular multiple low-density masses in the bilateral kidneys and an enhanced mass in the pituitary lesion of the brain. Magnetic resonance imaging (MRI) of the brain with gadolinium-DTPA contrast on the next day revealed the irregularly enhanced mass that occupied the sella turcica and measured 16x23x30 mm (Fig. 2) . The mass extended upwardto the suprasellar region, the infundibulum and the base of the third ventricle, and also extended downwardto the sphenoid sinus. The optic chiasm seemed to be involved in the mass. Because hypopituitarism was suspected on CTand MRIfindings which suggested pituitary metastasis of lung cancer, baseline hormone values were measured on January 7, and the results are summarizedin Table 1 . The baseline serum levels of cortisol, luteinizing hormone (LH), follicle-stimulating hormone(FSH), and testosterone were abnormally low. The serum prolactin (PRL) and growth hormone levels were mildly elevated. The plasma cortisol level and the 24-hour urinary cortisol was reduced and plasma adrenocorticotropic hormone (ACTH) level was normal, suggesting secondary adrenal insufficiency. Serum antidiuretic hormone (ADH)was normal. The chest radiograph showedthe tumor was growing, so systemic chemotherapy with 150 mg of cisplatin, 13 mg of mitomycin C, and 10 mgof vindesine sulfate was started on January 7. In addition, radiation to the pituitary metastasis was started on January 8 at a daily dose of 2 Gray continued up to the total dose of 40 Gray. Pituitary stimulation tests with corticotropin-releasing hormone (CRH) , thyrotropin-releasing hormone(TRH), growth hormone-releasing hormone (GHRH) and gonadotropin-releasing hormone (GnRH)were performed on January 14 ( Table 2 ). Thyroid stimulating hormone and PRL failed to respond to TRH.GHresponse to GHRH, as well as LH and FSH responses to GnRHwere slight and delayed. These observations suggested central hypothyroidism and hypogonadotropic hypogonadism.There was a normal ACTH response to CRH,probably because the secretion ofACTHhad partially recovered before the test was performed. Urine amount was 1,800 ml/day and it had not changed after the recovery of ACTHsecretion. Anterior hypopituitarism due to pituitary metastasis of lung cancer was diagnosed. Hydrocortisone, 40 mg daily, was given considering the relative shortage by systemic demandfor cortisol with the chemotherapeutic load. Levothyroxine, 25 |LLg daily, was given for hypothyroidism. The replacement therapy relieved him of his general malaise. Serum cytokeratin 1 9 fragment was decreased to 2.7 ng/ml on February 13, but the size of the tumor on the chest radiograph did not change significantly after the first chemotherapy. Although systemic chemotherapy was performed four times, multiple vertebral metastases and metastasis to the cervical supine were detected by whole body supine MRI. Serum cytokeratin 19 fragment becameelevated to an extremely high value of 70.0 ng/ml on April 27. On May 2, the patient died of sudden respiratory failure and coma, which were probably caused by the meningeal metastasis. Autopsy was not performed because permission was not obtained.
Discussion
Patients under 40 years of age with lung cancer have been reported to present in more advanced stage and to have a poorer prognosis compared to older patients (1, 2, 9). In one large series, only 21 of 31,266 patients (0.07%) with lung cancer were less than 29 years old, and only 1.2% were less than 39 years old (10) . Smoking is considered one of the risk factors for lung cancer even in young patients (1, 2, ll). The present patient had neither smoking history nor family history of cancer. Sekine et al. consider that genetic rather than environmental factors are primarily involved in carcinogenesis of lung cancer in young patients (12) . Lung cancer in the young is shown to have characteristics different from that in older patients, including a lower male-to-female ratio and a higher frequency of adenocarcinoma ( 1 1 ). However, the most important behavioral characteristic of lung cancer in young patients is its late stage presentation (1, 1 3). To our knowledge, there has been no previous reports on hypopituitarism due to pituitary metastasis from lung cancer in a patient as young as ours.
Pituitary metastasis occurs in only 1 to 6%of unselected autopsied cancer cases (14, 15) . Breast cancer is the most commonmalignancyto metastasize the pituitary gland in women and lung cancer is the most commonsource of pituitary metastasis in men (7) . Metastasis to the posterior lobe of the pituitary gland may cause diabetes insipidus (16) and metastasis to the anterior lobe maycause anterior hypopituitarism.
Metastasis to the pituitary gland should be distinguished from pituitary adenoma. A 3.3% incidence of pituitary metastasis is found in patients with cancer, while a 1.8% incidence of pituitary adenoma has been reported in a similar group of patients (4). Branch and Laws proposed that the clinical triad of head- CRH:corticotropin-releasing hormone, GHRH: growth hormone-releasing hormone, GnRH: gonadotropin-releasing hormone, TRH: thyrotropin-releasing hormone.
ache, extraocular nerve palsy and diabetes insipidus are highly suggestive of a metastasis to the sella regardless of whether the patient has been proven to have cancer (17) . The present patient had reported headache and double vision subjectively but there were no objective findings suggesting extraocular nerve palsy. There was no histopathologic diagnosis of the tumor occupying the sella turcica and the suprasellar region. Considering the MRI findings and endocrinologic findings, the most probable diagnosis for our case was lung cancer with metastasis to the hypophyseal region and direct invasion to the infundibulum, the bottom of the third ventricle and the surface of the sphenoid sinus. The fact that the posterior lobe of the pituitary is supplied with blood from the systemic circulation while the anterior lobe is supplied from the portal circulation accounts for the predilection of tumors for metastasis to the posterior pituitary glands (18) . A large part of the anterior pituitary has to be destroyed before hypopituitarism manifests (3) . In the present case, most of the intrasellar space was involved in the tumor. It is unclear which the anterior or the posterior lobe was the primary site of the pituitary metastasis. In cases involving both lobes, cancer cells are thought to extend directly from the posterior lobe. Kovacsconsidered that, in somecases, the cancer cells may have reached the anterior lobe from the median eminenceregion, from the pituitary stalk, from the capsular vessels, via the lymphatics, by direct extension from the adjacent bones, or along a retrograde route via the hypophysial veins (3). In the present case, GHand PRLwere elevated when the baseline levels were measured (Table 1) , thereafter, these hypersecretions improved before the pituitary function tests were performed (Table 2) . These results were probably due to the initial deficiency of cortisol followed by its recovery after the treatment was started. Another possible interpretation of the initial hyperprolactinemia is that hypothalamus-derived prolactin inhibiting factor, which is considered to be dopamine, is blocked by the infundibular invasion of the pituitary metastasis. Such a condition is thought to be rare (6, 17, 19) . Twentyfour-hour urinary 17-OHCS was within the normal range, which is inconsistent with the reduced plasma and urinary cortisol levels. The possible explanation for the result is that he took nutritional drinks containing ascorbic acid every day for the malaise. ACTHsecretion seemed to have recovered before the pituitary function test, whereas the other pituitary hormones had not responded to the stimulation test ( Table 2 ). The reason for this phenomenonis unclear. ADHlevel was normal in the initial evaluation and the urine volumedid not change after the cortisol level normalized. Based on the course, we considered that diabetes insipidus was absent in our patient.
The patient complained of general malaise, loss of appetite and decreased sexual desire at presentation. It was difficult to differentiate such symptomsdue to panhypopituitarism from the constitutional symptomscaused by cancer progression. Considering that the life expectancy is limited for advanced lung cancer patients, detection and appropriate treatment of hormonal insufficiency are important to improve their quality of life. Refere
